Labetuzumab (Anti-CEACAM5 / CEA / CD66e)

Catalog No.A2638 Batch: A263802

Technical Data

CAS No.	219649-07-7
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Isotype	Human IgG1
Source	CHO
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Purity	99%
Protein concentration	6.18mg/ml
Endotoxin Level	＜1EU/mg

Biological Activity

Description	Labetuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanised monoclonal antibody targeting carcinoembryonic antigen (CEA). It inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy. MW :145.36 KD.

References	[1] Stein R, et al. Mol Cancer Ther. 2004 Dec;3(12):1559-64.

References

[1] Stein R, et al. Mol Cancer Ther. 2004 Dec;3(12):1559-64.

FOR RESEARCH USE ONLY. NOT FOR USE IN HUMANS.

Specific storage and handling information for each product is indicated on the product datasheet. Most Selleck products are stable under the recommended conditions. Products are sometimes shipped at a temperature that differs from the recommended storage temperature. Short-term storage of many products are stable in the short-term at temperatures that differ from that required for long-term storage.
We ensure that the product is shipped under conditions that will maintain the quality of the reagents. Upon receipt of the product, follow the storage recommendations on the product data sheet.